Cargando…

CD4 T Cells and Their Role in Antitumor Immune Responses

Detalles Bibliográficos
Autores principales:	Toes, René E.M., Ossendorp, Ferry, Offringa, Rienk, Melief, Cornelis J.M.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1999
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192956/ https://www.ncbi.nlm.nih.gov/pubmed/10049938

Ejemplares similares

Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25(+) Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
por: Sutmuller, Roger P.M., et al.
Publicado: (2001)

Immature Dendritic Cells Acquire Cd8(+)Cytotoxic T Lymphocyte Priming Capacity upon Activation by T Helper Cell–Independent or–Dependent Stimuli
por: Schuurhuis, Danita H., et al.
Publicado: (2000)

Differential Influence on Cytotoxic T Lymphocyte Epitope Presentation by Controlled Expression of Either Proteasome Immunosubunits or Pa28
por: van Hall, Thorbald, et al.
Publicado: (2000)

Expression of the Serpin Serine Protease Inhibitor 6 Protects Dendritic Cells from Cytotoxic T Lymphocyte–Induced Apoptosis: Differential Modulation by T Helper Type 1 and Type 2 Cells
por: Medema, Jan Paul, et al.
Publicado: (2001)

Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein
por: Medema, Jan Paul, et al.
Publicado: (1999)

Local immunomodulation for cancer therapy: Providing treatment where needed
por: Fransen, Marieke F, et al.
Publicado: (2013)

Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors
por: Ossendorp, Ferry, et al.
Publicado: (1998)

Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine: Comparison of Prophylaxis and Therapy
por: van Elsas, Andrea, et al.
Publicado: (2001)

The viral context instructs the redundancy of costimulatory pathways in driving CD8(+) T cell expansion
por: Welten, Suzanne PM, et al.
Publicado: (2015)

Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy
por: Baumann, Daniel, et al.
Publicado: (2020)

The Central Role of CD4(+) T Cells in the Antitumor Immune Response
por: Hung, Kenneth, et al.
Publicado: (1998)

Roles of CD4+ T cells as mediators of antitumor immunity
por: Kravtsov, Dmitriy S., et al.
Publicado: (2022)

Efficient Identification of Novel Hla-A*0201–Presented Cytotoxic T Lymphocyte Epitopes in the Widely Expressed Tumor Antigen Prame by Proteasome-Mediated Digestion Analysis
por: Kessler, Jan H., et al.
Publicado: (2001)

Adipocytes from the infrapatellar fat pad of OA patients modulate CD4+ T cell cytokine production
por: Ioan-Facsinay, Andreea, et al.
Publicado: (2011)

Human Papillomavirus Deregulates the Response of a Cellular Network Comprising of Chemotactic and Proinflammatory Genes
por: Karim, Rezaul, et al.
Publicado: (2011)

Human Papillomavirus (HPV) Upregulates the Cellular Deubiquitinase UCHL1 to Suppress the Keratinocyte's Innate Immune Response
por: Karim, Rezaul, et al.
Publicado: (2013)

Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal adenocarcinoma
por: Liu, Xiaomeng, et al.
Publicado: (2022)

Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells
por: Kleijmeer, Monique, et al.
Publicado: (2001)

T-cell modulatory properties of CD5 and its role in antitumor immune responses
por: Tabbekh, Mouna, et al.
Publicado: (2013)

Control of Immune Responses by Naturally Arising CD4(+) Regulatory T Cells That Express Toll-like Receptors
por: Sakaguchi, Shimon
Publicado: (2003)

A Translational Perspective of a Deubiquitinase Inhibitor in Antitumor Immunity
por: Li, Yangyang, et al.
Publicado: (2016)

Inhibiting DNA methylation improves antitumor immunity in ovarian cancer
por: Chiappinelli, Katherine B., et al.
Publicado: (2022)

Untangling the CD4 T cell response to the microbiota
por: Mayassi, Toufic, et al.
Publicado: (2023)

Enhancing Antitumor Immunity with Antiangiogenic Therapy: A Clinical Model in Renal Cell Carcinoma?
por: Gao, Xin, et al.
Publicado: (2019)

Two types of biomarker-dependent chemo-immunotherapy for pancreatic cancer?
por: Melief, Cornelis J.M.
Publicado: (2022)

Peptide emulsions in incomplete Freund’s adjuvant create effective nurseries promoting egress of systemic CD4(+) and CD8(+) T cells for immunotherapy of cancer
por: Melssen, Marit M, et al.
Publicado: (2022)

Preclinical and Clinical Evidence of Immune Responses Triggered in Oncologic Photodynamic Therapy: Clinical Recommendations
por: Beltrán Hernández, Irati, et al.
Publicado: (2020)

Restoration of microRNA metabolism trigger robust antitumor responses
por: Bofill-De Ros, Xavier
Publicado: (2022)

Certified Professionals: Cd4(+)Cd25(+) Suppressor T Cells
por: Shevach, Ethan M.
Publicado: (2001)

Kinetics reshape antitumor immunity: Timing, duration, and combination are of importance for successful cancer immunotherapy
por: Jin, Seung Mo, et al.
Publicado: (2023)

Tumor Eradication by Wild-type p53-specific Cytotoxic T Lymphocytes
por: Vierboom, Michel P.M., et al.
Publicado: (1997)

Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights
por: Fransen, Marieke F., et al.
Publicado: (2021)

How do I steer this thing? Using dendritic cell targeted vaccination to more effectively guide the antitumor immune response with combination immunotherapy
por: Linch, Stefanie N., et al.
Publicado: (2016)

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?
por: Godet, Yann, et al.
Publicado: (2012)

The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses
por: Kalams, Spyros A., et al.
Publicado: (1998)

Progress in Defining CD4 Helper Cell Responses in Chronic Viral Infections
por: Day, Cheryl L., et al.
Publicado: (2003)

Mechanisms of oral tolerance revisited
por: Wang, Jun, et al.
Publicado: (2008)

Letter to the editor: Hypoxia kinetics and histology in combined radiotherapy and oxidative phosphorylation inhibition effects on antitumor immunity
por: Boreel, Daan F, et al.
Publicado: (2021)

Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication
por: Zom, Gijs G., et al.
Publicado: (2018)

Role of IL-16 in CD4(+) T cell-mediated regulation of relapsing multiple sclerosis
por: Skundric, Dusanka S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8q65ionkdn4jr3q7rm8vlee9lu